Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1985 2
1986 1
1987 2
1988 2
1990 1
1991 1
1993 1
1994 4
1995 1
1998 3
1999 4
2000 1
2001 1
2003 7
2004 5
2005 3
2006 3
2007 3
2008 3
2009 3
2010 11
2011 2
2012 5
2013 8
2014 4
2015 2
2016 12
2017 11
2018 3
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31204981

102 results
Results by year
Filters applied: . Clear all
Page 1
Anti-Xa assays: What is their role today in antithrombotic therapy?
Hutt Centeno E, Militello M, Gomes MP. Hutt Centeno E, et al. Cleve Clin J Med. 2019 Jun;86(6):417-425. doi: 10.3949/ccjm.86a.18029. Cleve Clin J Med. 2019. PMID: 31204981 Free article. Review.
Utilising a hybrid anti-Xa calibration assay in unfractionated heparin (UFH) monitoring: validation of assay and its correlation with activated partial thromboplastin time (aPTT).
Lukito P, Collecutt M, Dauer R, Morgan S, Tran H. Lukito P, et al. Pathology. 2016 Aug;48(5):501-3. doi: 10.1016/j.pathol.2016.04.006. Epub 2016 Jun 13. Pathology. 2016. PMID: 27306575 No abstract available.
Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
Kitchen S, Theaker J, Preston FE. Kitchen S, et al. Blood Coagul Fibrinolysis. 2000 Mar;11(2):137-44. Blood Coagul Fibrinolysis. 2000. PMID: 10759006
A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
Vandiver JW, Vondracek TG. Vandiver JW, et al. Hosp Pract (1995). 2013 Apr;41(2):16-24. doi: 10.3810/hp.2013.04.1022. Epub 2013 Apr 1. Hosp Pract (1995). 2013. PMID: 23545756
Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R. Raivio P, et al. Thromb Haemost. 2008 Feb;99(2):427-34. doi: 10.1160/TH07-04-0307. Thromb Haemost. 2008. PMID: 18278195 Clinical Trial.
The PiCT® test is a reliable alternative to the activated partial thromboplastin time in unfractionated heparin therapy management: results from a multicenter study.
Brisset AC, Ferrández A, Krause M, Rathbun S, Marlar R, Korte W. Brisset AC, et al. J Thromb Haemost. 2016 Nov;14(11):2187-2193. doi: 10.1111/jth.13489. Epub 2016 Oct 19. J Thromb Haemost. 2016. PMID: 27582411 Free article.
Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.
Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Porte RJ, Lisman T. Potze W, et al. Br J Haematol. 2013 Dec;163(5):666-73. doi: 10.1111/bjh.12593. Epub 2013 Oct 8. Br J Haematol. 2013. PMID: 24219333
Effects of four commercially available factor Xa proteins on the fluorogenic anti-factor Xa assay when monitoring unfractionated heparin.
Castro-López V, Murray B, Harris LF, O'Donnell JS, Killard AJ. Castro-López V, et al. Blood Coagul Fibrinolysis. 2012 Jan;23(1):98-103. doi: 10.1097/MBC.0b013e32834ddf4d. Blood Coagul Fibrinolysis. 2012. PMID: 22089943
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
Rosenberg AF, Zumberg M, Taylor L, LeClaire A, Harris N. Rosenberg AF, et al. J Pharm Pract. 2010 Jun;23(3):210-6. doi: 10.1177/0897190010362172. Epub 2010 May 6. J Pharm Pract. 2010. PMID: 21507816 Review.
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
Guervil DJ, Rosenberg AF, Winterstein AG, Harris NS, Johns TE, Zumberg MS. Guervil DJ, et al. Ann Pharmacother. 2011 Jul;45(7-8):861-8. doi: 10.1345/aph.1Q161. Epub 2011 Jun 28. Ann Pharmacother. 2011. PMID: 21712506
102 results
Jump to page